| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AngioDynamics Inc (NASDAQ: ANGO)
ANGO Technical Analysis
5
| As on 9th Jun 2023 ANGO SHARE Price closed @ 10.79 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 20.77 & Strong Sell for SHORT-TERM with Stoploss of 23.55 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ANGOSHARE Price
| Open | 10.20 | Change | Price | % |
| High | 11.14 | 1 Day | 0.80 | 8.01 |
| Low | 10.03 | 1 Week | 1.33 | 14.06 |
| Close | 10.79 | 1 Month | 2.50 | 30.16 |
| Volume | 1372100 | 1 Year | -15.86 | -59.51 |
| 52 Week High 29.16 | 52 Week Low 8.29 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ANGO Daily Charts |
ANGO Intraday Charts |
Whats New @ Bazaartrend |
ANGO Free Analysis |
|
|
ANGO Important Levels Intraday
| RESISTANCE | 12.93 |
| RESISTANCE | 12.24 |
| RESISTANCE | 11.82 |
| RESISTANCE | 11.39 |
| SUPPORT | 10.19 |
| SUPPORT | 9.76 |
| SUPPORT | 9.34 |
| SUPPORT | 8.65 |
ANGO Forecast April 2024
| 4th UP Forecast | 18.61 |
| 3rd UP Forecast | 16.1 |
| 2nd UP Forecast | 14.55 |
| 1st UP Forecast | 13 |
| 1st DOWN Forecast | 8.58 |
| 2nd DOWN Forecast | 7.03 |
| 3rd DOWN Forecast | 5.48 |
| 4th DOWN Forecast | 2.97 |
ANGO Weekly Forecast
| 4th UP Forecast | 15.72 |
| 3rd UP Forecast | 14.14 |
| 2nd UP Forecast | 13.16 |
| 1st UP Forecast | 12.19 |
| 1st DOWN Forecast | 9.39 |
| 2nd DOWN Forecast | 8.42 |
| 3rd DOWN Forecast | 7.44 |
| 4th DOWN Forecast | 5.86 |
ANGO Forecast2024
| 4th UP Forecast | 52.84 |
| 3rd UP Forecast | 39.35 |
| 2nd UP Forecast | 31.02 |
| 1st UP Forecast | 22.68 |
| 1st DOWN Forecast | -1.1 |
| 2nd DOWN Forecast | -9.44 |
| 3rd DOWN Forecast | -17.77 |
| 4th DOWN Forecast | -31.26 |
AngioDynamics Inc ( NASDAQ USA Symbol : ANGO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ANGO Business Profile
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York. Address: 14 Plaza Drive, Latham, NY, United States, 12110
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service